Press release
Global Non-Invasive Prenatal Testing Market Report by Component (Instruments, Kits and Reagents, Services) Application (Down Syndrome (trisomy 21), Edwards Syndrome (trisomy 18), Patau Syndrome (trisomy 13), Turner Syndrome, Other Applications) End User (
The global non-invasive prenatal testing (NIPT) market is set to expand significantly, projected to reach USD 9.98 billion by 2032, up from USD 3.19 billion in 2023. This impressive growth reflects a compound annual growth rate (CAGR) of 13.51% from 2024 to 2032. Key drivers behind this expansion include advancements in genetic screening techniques, an increase in maternal age, and a growing understanding of NIPT's benefits.
Global Non-Invasive Prenatal Testing Market Table of Content and Sample Download https://www.renub.com/non-invasive-prenatal-testing-market-p.php
Non-Invasive Prenatal Testing (NIPT)
Non-invasive prenatal testing (NIPT) is a modern technique used to analyze cell-free fetal DNA circulating in the maternal blood to detect chromosomal abnormalities such as Down, Edwards, and Patau syndromes. Unlike invasive methods like amniocentesis and chorionic villus sampling (CVS), which carry risks of miscarriage due to their direct examination of amniotic fluid or placental tissue, NIPT poses no such risk as it relies solely on a blood sample from the pregnant woman.
NIPT offers numerous advantages over traditional methods, including higher accuracy in detecting chromosomal abnormalities, the ability to be performed early in pregnancy (within the first 9-10 weeks), and the provision of additional information about fetal sex and certain inherited diseases. This method has become a safe, efficient technology that delivers critical information to expectant parents and clinicians, aiding in decision-making regarding further diagnostic procedures or management strategies.
Drivers of Growth in the NIPT Market
Technological Advancements: Advancements in genetic sequencing technologies and bioinformatics have significantly enhanced the accuracy and reliability of NIPT. Innovations such as next-generation sequencing (NGS) and improved bioinformatics algorithms have refined the ability to identify fetal chromosomal abnormalities using maternal blood samples. These technological improvements have established NIPT as a safer alternative to invasive procedures like amniocentesis and CVS, while maintaining its high sensitivity for detecting conditions such as Down syndrome and other trisomies.
Rising Maternal Age: The trend of advanced maternal age, particularly in developed countries, is a significant factor driving the NIPT market. Women over the age of 35 are at a higher risk of having a baby with chromosomal abnormalities, leading to increased demand for early and reliable prenatal testing methods like NIPT. Additionally, societal trends towards delaying childbirth further contribute to the rising need for advanced prenatal screening options.
Growing Awareness and Acceptance: The benefits of NIPT, including its non-invasive nature, early detection capability, and high accuracy rates, have become well-known among expectant parents and healthcare providers. Increasing public awareness, positive clinical data, and endorsements from physicians have positioned NIPT as a preferred choice for prenatal screening globally.
Expanding Applications and Accessibility: NIPT is evolving beyond simple chromosomal abnormalities to include assessments for microdeletions, sex chromosome aneuploidies, and specific single-gene disorders. Advances in healthcare infrastructure, particularly in emerging regions, are enhancing the accessibility of NIPT services. As technology advances and costs potentially decrease, NIPT is expected to become more widely available and integrated into prenatal care across various healthcare settings.
Asia-Pacific Non-Invasive Prenatal Testing Market
The Asia-Pacific region is witnessing significant growth in the NIPT market due to technological advancements and increased healthcare spending. China, with its large population and growing middle class seeking better healthcare services, leads the market. Government investments in healthcare facilities also support the adoption of NIPT. Japan and South Korea are notable for their advanced technology and high-quality healthcare systems, adopting NIPT as a primary prenatal screening method. Factors such as an aging population and a focus on maternity and fetal health contribute to the market's growth in these countries.
India and Southeast Asia are emerging markets driven by rising middle-income groups, improved healthcare facilities, and increased awareness of prenatal screening benefits. As NIPT becomes more accessible and affordable in these regions, its market potential continues to expand. The combination of demographic trends, technological innovations, and improved healthcare expenditure presents significant opportunities for the NIPT market in the Asia-Pacific region.
Non-Invasive Prenatal Testing Company Overview
Key players in the global NIPT market include Eurofins Scientific, F. Hoffmann-La Roche Ltd, Invitae Corporation, Illumina Inc., Natera Inc., Centogene, and Qiagen.
Recent Developments in Non-Invasive Prenatal Testing
September 2023: Yourgene Health plc introduced the Yourgene MagBench Automated DNA Extraction Instrument and Kit, designed for efficient cell-free DNA extraction. This solution supports the Sage 32 NIPT Workflow and is available to clients in the Asia-Pacific and Middle East regions, enhancing clinical laboratory capabilities for NIPT services.
August 2022: Natera Inc. submitted a pre-submission to the Food and Drug Administration (FDA) for its panoramic NIPT, including tests for 22q 11.2 deletion syndrome and fetal chromosomal aneuploidies. This submission represents a significant step towards expanding NIPT's diagnostic capabilities.
Relate Reports
Diagnostic Imaging Market: https://www.renub.com/diagnostic-imaging-market-p.php
Amniotic Membrane Market: https://www.renub.com/amniotic-membrane-market-p.php
Prostate Cancer Diagnostics Market: https://www.renub.com/prostate-cancer-diagnostics-market-p.php
Molecular Diagnostics Market: https://www.renub.com/global-molecular-diagnostics-market-opportunities-and-future-forecast-414-p.php
Component - Global Non-Invasive Prenatal Testing Market in 3 Viewpoints -
1. Instruments
2. Kits and Reagents
3. Services
Application - Global Non-Invasive Prenatal Testing Market in 5 Viewpoints -
1. Down Syndrome (trisomy 21)
2. Edwards Syndrome (trisomy 18)
3. Patau Syndrome (trisomy 13)
4. Turner Syndrome
5. Other Applications
End User - Global Non-Invasive Prenatal Testing Market in 2 Viewpoints -
1. Hospitals
2. Diagnostic Labs
Geography - Global Non-Invasive Prenatal Testing Market
North America
1. United States
2. Canada
Europe
1. France
2. Germany
3. Italy
4. Spain
5. United Kingdom
6. Belgium
7. Netherlands
8. Turkey
Asia Pacific
1. China
2. Japan
3. India
4. Australia
5. South Korea
6. Thailand
7. Malaysia
8. Indonesia
9. New Zealand
Latin America
1. Brazil
2. Mexico
3. Argentina
Middle East & Africa
1. South Africa
2. Saudi Arabia
3. United Arab Emirates
Company Insights:
• Overviews
• Recent Developments & Strategies
• Revenue
Company Analysis:
1. Eurofins Scientific
2. F. Hoffmann-La Roche Ltd
3. Invitae Corporation
4. Illumina Inc.
5. Natera Inc.
6. Centogene NV
7. Qiagen
About the Company:
Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 9000 syndicated reports and worked on more than 750 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.
Media Contact:
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Address: 225 Kristie Ln, Roswell, GA 30076
Email: info@renub.com
LinkedIn: https://linkedin.com/company/renub-research
Website: www.renub.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Non-Invasive Prenatal Testing Market Report by Component (Instruments, Kits and Reagents, Services) Application (Down Syndrome (trisomy 21), Edwards Syndrome (trisomy 18), Patau Syndrome (trisomy 13), Turner Syndrome, Other Applications) End User ( here
News-ID: 3596869 • Views: …
More Releases from Renub Resaecrh
Global Sports Medicine Market to Hit $12.32 Billion by 2033, Driven by Rising At …
Sports Medicine Market Overview
The growing awareness of injury prevention, increased involvement in sports and physical activities, and advancements in medical technology are all contributing to the notable rise of the global sports medicine industry. The prevention, diagnosis, treatment, and rehabilitation of sports-related injuries are the primary goals of this specialized discipline, which serves athletes, fitness enthusiasts, and individuals who lead active lifestyles. The adoption of less invasive surgical procedures, the…
U.S. Cosmetics Industry Set to Surge Past $149 Billion by 2033 Amid Rising Deman …
United States Cosmetics Market Overview
According to Renub Research, with an absolute compound annual growth rate (CAGR) of 4.82% from 2025 to 2033, the United States cosmetics industry is expected to reach around US$ 149.53 billion in 2033, up from US$ 97.89 billion in 2024.
Growing consumer awareness of personal grooming and beauty improvement, particularly among millennial and Gen Z, is the primary factor driving the US industry. For example, according to…
Global Non-Invasive Prenatal Testing Market to Triple by 2033, Surging to US$ 11 …
Non-Invasive Prenatal Testing Market Overview
A type of prenatal screening called non-invasive prenatal testing (NIPT) uses a pregnant woman's blood sample to check for fetal abnormalities. By examining DNA fragments in the mother's blood, the test is primarily used to identify genetic abnormalities, such as Turner syndrome, Patau syndrome, Edwards syndrome, and Down syndrome. The treatment, which may be carried out after nine weeks of pregnancy, removes the need…
Renub Research: Global Tractor Market Set to Plough Ahead, Reaching $111.22 Bill …
Agricultural Tractors Market Overview
The growing need for automated solutions in contemporary farming is driving the rapid evolution of the agricultural tractor market. Precision agriculture, less manual work, and increased output are all made possible by tractors. To maximize field operations, farmers are implementing tractors equipped with cutting-edge technology, such as automation, telematics, and GPS, as the global demand for food increases. Trends such as climate change adaptation and sustainable…
More Releases for NIPT
NonInvasive Prenatal Testing (NIPT) Market Analysis: Understanding Trends, Playe …
"Non-Invasive Prenatal Testing (Nipt) Market Is Estimated To Be US$ 11.8 Billion By 2030 With A Cagr Of 11.9% During Forecast Period".
With thorough company profiles, recent developments, and other information, the NonInvasive Prenatal Testing (NIPT) Market Report provides an in-depth analysis of major trends, motivating reasons, obstacles, segmentation, regulatory policies, and important players. The NonInvasive Prenatal Testing (NIPT) Market Report offers a thorough synopsis of the product portfolio, including product…
Noninvasive Prenatal Testing (NIPT) Market | Counsyl, Illuminansyl, Intergrated …
The global noninvasive prenatal testing (nipt) market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the noninvasive prenatal testing (nipt) market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving…
United States Non-Invasive Prenatal Testing(NIPT) Market Trends, Upcoming Techno …
United States Non-Invasive Prenatal Testing(NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023.
Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT, shifting trend towards child bearing at advanced maternal age (35 years or older), launch of new and advanced…
Leading Brands of Non-Invasive Prenatal Testing (NIPT) Industry | By IMARC Group
Non-Invasive Prenatal Testing (NIPT) Industry Outlook:
Non-invasive prenatal testing (NIPT) refers to a form of prenatal screening conducted on a pregnant woman blood sample to detect the presence of fetal abnormalities. The test is mainly used to diagnose genetic disorders, such as Down syndrome (or trisomy 21), Edwards syndrome (or trisomy 18), Patau syndrome (or trisomy 13), and Turner syndrome by analyzing DNA fragments in the blood. NIPT includes ultrasound detection,…
Digital Healthcare Marketing to Drive the Non Invasive Prenatal Testing Nipt Mar …
The Non Invasive Prenatal Testing Nipt Market is all set to go great guns in the forecast period. Big data makes way for real-time data visualization, thereby identifying the high-risk populations. Healthcare organizations are into sharing more data. This creation and collection of bigger datasets are likely to increase precision and help organizations in spotting trends. These trends are expected to keep the entire healthcare vertical on the toes.
Advancing the…
The Non Invasive Prenatal Testing NIPT Market To Be Revolutionized By IoT
The Non-Invasive Prenatal Testing Nipt Market Share is expected to reach US$ 850 Million between 2024 at a CAGR of 10.2%. Speedy development on the part of ICT does bring in new-fangled advantages like more autonomy to patients along with the promotion of interagency collaboration. As such, the ones with comorbidities and multidimensional problems would find themselves safe. This increased dependency is bound to drive the healthcare vertical going forward.
Advancing…
